GE HealthCare Technologies Inc.
For the period ended Dec 31, 2025. Filed Feb 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GE HealthCare Technologies Inc. | |
| (Registrant) | |
| February 4, 2026 | /s/ James K. Saccaro |
|---|---|
| Date | James K. Saccaro, Vice President & Chief Financial Officer (Principal Financial Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 4, 2026.
| Signature | /s/ Peter J. Arduini |
|---|---|
| Title | Peter J. Arduini, President & Chief Executive Officer and Director (Principal Executive Officer) |
| /s/ James K. Saccaro | |
| James K. Saccaro, Vice President & Chief Financial Officer (Principal Financial Officer) | |
| /s/ George A. Newcomb | |
| George A. Newcomb, Chief Accounting Officer (Principal Accounting Officer) | |
| /s/ H. Lawrence Culp, Jr. | |
| H. Lawrence Culp, Jr., Chairman of the Board of Directors | |
| /s/ Rodney F. Hochman | |
| Rodney F. Hochman, Director | |
| /s/ Risa Lavizzo-Mourey | |
| Risa Lavizzo-Mourey, Director | |
| /s/ Catherine Lesjak | |
| Catherine Lesjak, Director | |
| /s/ Anne T. Madden | |
| Anne T. Madden, Director | |
| /s/ Tomislav Mihaljevic | |
| Tomislav Mihaljevic, Director | |
| /s/ William J. Stromberg | |
| William J. Stromberg, Director | |
| /s/ Phoebe L. Yang | |
| Phoebe L. Yang, Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.